|
13/11/2024
|
17:06
|
Holding(s) in Company
|
RNS
|
|
13/11/2024
|
11:41
|
Holding(s) in Company
|
RNS
|
|
12/11/2024
|
17:17
|
Holding(s) in Company
|
RNS
|
|
12/11/2024
|
16:49
|
Holding(s) in Company
|
RNS
|
|
11/11/2024
|
11:15
|
Director/PDMR Shareholding
|
RNS
|
|
08/11/2024
|
14:37
|
Results of General Meeting and Total Voting Rights
|
RNS
|
|
31/10/2024
|
17:07
|
Result of Retail Offer
|
RNS
|
|
31/10/2024
|
07:00
|
Trading Update
|
RNS
|
|
23/10/2024
|
16:12
|
Posting of Circular and Notice of General Meeting
|
RNS
|
|
18/10/2024
|
15:05
|
Result of Placing & Issue of Equity
|
RNS
|
|
18/10/2024
|
08:00
|
Retail Offer
|
RNS
|
|
18/10/2024
|
07:47
|
Fundraising and Amendments to Facility
|
RNS
|
|
09/09/2024
|
07:00
|
Trading Update
|
RNS
|
|
02/09/2024
|
07:00
|
Contract Win
|
RNS
|
|
09/08/2024
|
07:00
|
US$1.5m Contract Win with Top 10 Pharma Company
|
RNS
|
|
24/06/2024
|
11:18
|
Holding(s) in Company
|
RNS
|
|
17/06/2024
|
14:30
|
Holding(s) in Company
|
RNS
|
|
29/05/2024
|
17:45
|
Holding(s) in Company
|
RNS
|
|
21/05/2024
|
07:00
|
Interim Results
|
RNS
|
|
17/05/2024
|
10:11
|
Investor Presentation via Investor Meet Company
|
RNS
|
|
09/05/2024
|
15:08
|
Holding(s) in Company
|
RNS
|
|
26/04/2024
|
07:00
|
Appointment of Nominated Adviser and Joint Broker
|
RNS
|
|
25/04/2024
|
10:44
|
Holding(s) in Company
|
RNS
|
|
02/04/2024
|
11:34
|
Result of General Meeting
|
RNS
|
|
02/04/2024
|
08:00
|
Total Voting Rights
|
RNS
|
|
26/03/2024
|
11:18
|
Holding(s) in Company
|
RNS
|
|
13/03/2024
|
17:32
|
Block Listing Return
|
RNS
|
|
06/03/2024
|
15:02
|
Posting of Notice of General Meeting
|
RNS
|
|
01/03/2024
|
13:00
|
Investor Presentation via Investor Meet Company
|
RNS
|
|
29/02/2024
|
11:19
|
Holding(s) in Company
|
RNS
|
|
29/02/2024
|
07:00
|
Final Results
|
RNS
|
|
26/02/2024
|
11:30
|
Result of AGM
|
RNS
|
|
02/02/2024
|
07:00
|
Notice of AGM
|
RNS
|
|
11/12/2023
|
15:12
|
Director/PDMR Shareholding
|
RNS
|
|
08/12/2023
|
14:31
|
Grant of Options and PDMR Dealing
|
RNS
|
|
30/11/2023
|
07:00
|
Progress against Strategy
|
RNS
|
|
10/11/2023
|
10:14
|
Holding(s) in Company
|
RNS
|
|
07/11/2023
|
16:11
|
Grant of Options and PDMR Dealing
|
RNS
|
|
19/10/2023
|
07:00
|
Investor Presentation via Investor Meet Company
|
RNS
|
|
12/10/2023
|
07:00
|
Update on Strategy & Changes to the Board
|
RNS
|
|
01/08/2023
|
07:00
|
Board Changes
|
RNS
|
|
14/07/2023
|
14:00
|
Corrected unaudited interim results to 31 May 2022
|
RNS
|
|
12/07/2023
|
07:00
|
Appointment of new leadership team & board changes
|
RNS
|
|
26/06/2023
|
11:10
|
Change of registered office
|
RNS
|
|
23/06/2023
|
07:00
|
Transition of Executive Leadership
|
RNS
|
|
15/06/2023
|
17:16
|
Correction to interim results
|
RNS
|
|
13/06/2023
|
07:45
|
Holding(s) in Company
|
RNS
|
|
05/06/2023
|
16:02
|
Director/PDMR Shareholding
|
RNS
|
|
31/05/2023
|
07:00
|
Interim Results
|
RNS
|
|
22/05/2023
|
07:00
|
Sale of Oncimmune Limited to Freenome
|
RNS
|